Estudo anatômico e identificação química da cera cuticular de folhas de Heliconia aff. tarumaensis Barreiros (Heliconiaceae)

Leaf anatomy and chemical identification of cuticular wax of a species of Heliconia related to H. tarumaensis are presented here. The anatomical structure of the leaf is suggestive of a sun plant, and this agrees with the known habitat of the species. Rhexigenous lacunae are present both in the petiole and midrib of the leaf blade. The proportion of photosynthetic tissue is low, never occupying more than 1/2 of the thickness of the leaf. The cuticular wax was identified as n-tetra-cosyl laurate.A anatomia foliar e a identificação química da cera cuticular da folha de uma espécie de Heliconia, afima H. tarumaensis, são apresentadas neste trabalho. A estrutura anatômica da folha é sugestiva de uma planta heliófita, o que concorda bem com os habitats conhecidos para ela. É de notar-se a presença de canais rexígenos, tanto na nervura central quanto no pecíolo. Também são interessantes as baixas proporções de tecido parenquimático, que nunca chegam a ocupar mais da metade da espessura da lâmina. A cera cuticular foi identificada como laurato de n-tetracosila em sua totalidade

Aristolactama y esteróles del tallo de piper chiadoense

Del extracto etanólico del tallo de Piper chiadoense Junker (Piperaceae) fueron aislados por métodos cromatográficos la aristolactama identificada como lactama del ácido 10-amino-3,4-dimetoxifenantreno-l carboxílico (cepharanone B); campesterol; estigmasterol y B-sitosterol. Sus estructuras fueron determinadas por métodos espectroscópicos y por comparación con datos reportados en la literatura

The chemistry of Brazilian Lauraceae XLVI. Notes on Aniba species

Aniba affinis, A. cylindriflora and A. mas (Lauraceae) were found to contain respectively benzofuranoid (and a previously unknown bicyclo [3, 2, 1] octanoid) neolignans, 6-styryl-2-pyrones and 6-styryl-4-methoxy-2-pyrones.A madeira do tronco das espécies amazônicas Aniba affinis, A. cylindriflora e A. mas contém respectivamente neolignanas benzofuranoídicas (e uma biciclo [3, 2, 1] octanoídica previamente desconhecida), 6-estiril-2-pironas e 6-estiril-4-metoxi-2-pironas

Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study

Background Results from retrospective studies suggest that use of neuromuscular blocking agents during general anaesthesia might be linked to postoperative pulmonary complications. We therefore aimed to assess whether the use of neuromuscular blocking agents is associated with postoperative pulmonary complications. Methods We did a multicentre, prospective observational cohort study. Patients were recruited from 211 hospitals in 28 European countries. We included patients (aged ≥18 years) who received general anaesthesia for any in-hospital procedure except cardiac surgery. Patient characteristics, surgical and anaesthetic details, and chart review at discharge were prospectively collected over 2 weeks. Additionally, each patient underwent postoperative physical examination within 3 days of surgery to check for adverse pulmonary events. The study outcome was the incidence of postoperative pulmonary complications from the end of surgery up to postoperative day 28. Logistic regression analyses were adjusted for surgical factors and patients’ preoperative physical status, providing adjusted odds ratios (ORadj) and adjusted absolute risk reduction (ARRadj). This study is registered with ClinicalTrials.gov, number NCT01865513. Findings Between June 16, 2014, and April 29, 2015, data from 22803 patients were collected. The use of neuromuscular blocking agents was associated with an increased incidence of postoperative pulmonary complications in patients who had undergone general anaesthesia (1658 [7·6%] of 21694); ORadj 1·86, 95% CI 1·53–2·26; ARRadj –4·4%, 95% CI –5·5 to –3·2). Only 2·3% of high-risk surgical patients and those with adverse respiratory profiles were anaesthetised without neuromuscular blocking agents. The use of neuromuscular monitoring (ORadj 1·31, 95% CI 1·15–1·49; ARRadj –2·6%, 95% CI –3·9 to –1·4) and the administration of reversal agents (1·23, 1·07–1·41; –1·9%, –3·2 to –0·7) were not associated with a decreased risk of postoperative pulmonary complications. Neither the choice of sugammadex instead of neostigmine for reversal (ORadj 1·03, 95% CI 0·85–1·25; ARRadj –0·3%, 95% CI –2·4 to 1·5) nor extubation at a train-of-four ratio of 0·9 or more (1·03, 0·82–1·31; –0·4%, –3·5 to 2·2) was associated with better pulmonary outcomes. Interpretation We showed that the use of neuromuscular blocking drugs in general anaesthesia is associated with an increased risk of postoperative pulmonary complications. Anaesthetists must balance the potential benefits of neuromuscular blockade against the increased risk of postoperative pulmonary complications